nach oben

Neurological Sciences

Erschienen in:

27.11.2020 | Original Article

Male patients with neuromyelitis optica spectrum disorders: different clinical characteristics and worse steroid treatment response

verfasst von: Rui Li, Cong Li, Zhifeng Mao, Qiao Huang, Yaqing Shu, Yanyu Chang, Jingqi Wang, Yuge Wang, Wei Qiu

Erschienen in: Neurological Sciences | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Clinical data on male neuromyelitis optica spectrum (NMO) patients remain limited to date.

Objective

To analyze clinical characteristics, therapeutic responses, and outcomes in Chinese male NMOSD patients.

Methods

We retrospectively assessed clinical, demographic, treatment, and outcome data of male patients with NMOSD.

Results

We identified 52 male patients among 471 NMOSD patients. Male patients had more frequent optic neuritis (ON) attacks and less frequent myelitis than female patients. No-remission rates of high-dose intravenous steroid therapy were higher in male patients than in female patients.

Conclusion

Male NMOSD patients had different clinical characteristics and worse response to high-dose intravenous steroid therapy than female patients.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG, International Panel for NMO Diagnosis (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189. https://doi.org/10.1212/WNL.0000000000001729CrossRefPubMedPubMedCentral

Banerjee A, Ng J, Coleman J, Ospina JP, Mealy M, Levy M (2019) Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatment. Mult Scler Relat Disord 28:60–63CrossRef

Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weissert R, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Rückriem L, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Hellwig K, NEMOS (Neuromyelitis Optica Study Group) (2017) Influence of female sex and fertile age on neuromyelitis optica spectrum disorders. Mult. Scler. 23(8):1092–1103CrossRef

Kim SM, Waters P, Woodhall M, Kim YJ, Kim JA, Cheon SY, Lee S, Jo SR, Kim DG, Jung KC, Lee KW, Sung JJ, Park KS (2017) Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G. Mult. Scler. 23(8):1104–1111. https://doi.org/10.1177/1352458516674366CrossRefPubMed

Kunchok A, Malpas C, Nytrova P, Havrdova EK, Alroughani R, Terzi M, Yamout B, Hor JY, Karabudak R, Boz C, Ozakbas S, Olascoaga J, Simo M, Granella F, Patti F, McCombe P, Csepany T, Singhal B, Bergamaschi R, Fragoso Y, Al-Harbi T, Turkoglu R, Lechner-Scott J, Laureys G, Oreja-Guevara C, Pucci E, Sola P, Ferraro D, Altintas A, Soysal A, Vucic S, Grand'Maison F, Izquierdo G, Eichau S, Lugaresi A, Onofrj M, Trojano M, Marriott M, Butzkueven H, Kister I, Kalincik T (2020) Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 38:101868. https://doi.org/10.1016/j.msard.2019.101868CrossRefPubMed

Lin CW, Lin IH, Chen TC, Jou JR, Woung LC (2019) Clinical course and treatment response of neuromyelitis optica spectrum disease: an 8-year experience. Asia Pac J Ophthalmol 8(3):206–210. https://doi.org/10.22608/APO.2018247CrossRef

Wingerchuk DM (2009) Neuromyelitis optica: effect of gender. J. Neurol. Sci. 286(1-2):18–23. https://doi.org/10.1016/j.jns.2009.08.045CrossRefPubMed

Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485–1489CrossRef

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Bergh FT, Oy UH, Oliver Neuhaus 23, Alexander Winkelmann 24, Wael Marouf 25, Jürgen Faiss 3, Wildemann O, Paul F, Jarius S, Trebst C, Neuromyelitis Optica Study Group (2016) Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses. Ann. Neurol. 79(2):206–216CrossRef

10.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Krumbholz M, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl UK, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, NEMOS (Neuromyelitis Optica Study Group) (2016) Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions. Neurol Neuroimunol Neuroinflamm 5(6):e504CrossRef

11.

Jeong IH, Kim HJ, Kim N-H, Jeong KS, Park CY (2016) Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder. J. Neurol. 263(7):1343–1348CrossRef

12.

Cerghet M, Skoff RP, Swamydas M, Bessert D (2009) Sexual dimorphism in the white matter of rodents. J. Neurol. Sci. 286(1-2):76–80CrossRef

13.

Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R, Takai Y, Takahashi T, Misu T, Elsone L, Woodhall M, George J, Boggild M, Vincent A, Jacob A, Fujihara K, Palace J (2012) Prognostic factors and disease course in aquaporin-4 antibody positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 135(Pt 6):1834–1849CrossRef

14.

Mao Z, Yin J, Zhong X, Zhao Z, Qiu W, Lu Z, Hu X (2015) Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population. BMC Neurol. 15:160CrossRef

15.

Brotfain E, Gruenbaum SE, Boyko M, Kutz R, Zlotnik A, Klien M (2016) Neuroprotection by estrogen and progesterone in traumatic brain injury and spinal cord injury. Curr. Neuropharmacol. 14(6):641–653CrossRef

16.

Collongues N, Patte-Mensah C, De Seze J, Mensah-Nyagan AG, Derfuss T (2018) Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics. Expert. Rev. Neurother. 18(6):515–522CrossRef

Titel: Male patients with neuromyelitis optica spectrum disorders: different clinical characteristics and worse steroid treatment response
verfasst von: Rui Li
Cong Li
Zhifeng Mao
Qiao Huang
Yaqing Shu
Yanyu Chang
Jingqi Wang
Yuge Wang
Wei Qiu
Publikationsdatum: 27.11.2020
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 8/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04933-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Male patients with neuromyelitis optica spectrum disorders: different clinical characteristics and worse steroid treatment response

Abstract

Background

Objective

Methods

Results

Conclusion

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2021

Impact of dietary polyphenols on neuroinflammation-associated disorders

White matter hyperintensity determines ischemic stroke severity in symptomatic carotid artery stenosis

The efficacy of ultrasound-guided stellate ganglion block in alleviating postoperative pain and ventricular arrhythmias and its application prospects

Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease: a meta-analysis

Temporal and extratemporal atrophic manifestation of temporal lobe epilepsy using voxel-based morphometry and corticometry: clinical application in lateralization of epileptogenic zone

Central pontine myelinolysis secondary to rapid correction of hyponatremia historical perspective with Doctor Robert Laureno

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie